AffRegion.i
Exploration
Accueil
Racine
Exploration
Accueil

Gentilly AND (oncology OR urology) - Exploration (Accueil)

Index « AffRegion.i » - entrée « Occitanie (région administrative) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nouvelle-Galles du Sud < Occitanie (région administrative) < Pays de la Loire  Facettes :

List of bibliographic references indexed by Occitanie (région administrative)

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]**** probable Xml problem ****
Ident.Authors (with country if any)Title
000000 (2024) Ang Xe9 Line Galvin [France] ; Nicolas Bertrand ; Rabia Boulahssass ; Laure De Decker ; Etienne Dorval [France] ; B Xe9 Atrice Clairaz [France] ; Monique Castaign Xe8 De [France] ; Loic Mourey ; Capucine Baldini [France] ; Eric Bauvin [France] ; B Xe9 Atrice Jacques [France] ; Isabelle Mallon [France] ; Isabelle Durand-Zaleski [France] ; Olivier Gu Xe9 Rin [France] ; Sadek Krouri [France] ; Pierre SoubeyranRethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group.
000004 (2023) Karen Leroy [France] ; Clarisse Audigier Valette [France] ; J Xe9 R Xf4 Me Alexandre [France] ; Lise Boussemart [France] ; Jean Chiesa [France] ; Clotilde Deldycke [France] ; Carlos Gomez-Rocca [France] ; Antoine Hollebecque [France] ; Jacqueline Lehmann-Che [France] ; Antoinette Lemoine [France] ; Sandrine Mansard [France] ; Jacques Medioni [France] ; Isabelle Monnet [France] ; Samia Mourah [France] ; Thomas Pierret [France] ; Dominique Spa Xeb Th [France] ; Alexandre Civet [France] ; Sandrine Galoin [France] ; Antoine Italiano [France]Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
000005 (2023) Helo Xef Se Bourien [France] ; Le Xef La Bengrine Lefevre [France] ; Marie-Ange Mouret-Reynier [France] ; Bernard Asselain [France] ; Brigitte Lucas [France] ; Celine Gavoille [France] ; Corina Cornila [France] ; Laurene Gavoille [France] ; Emeline Colomba [France] ; Anne Patsouris [France] ; Michel Fabbro [France] ; Camille Chakiba [France] ; Philippe Toussaint [France] ; Helene Simon [France] ; Dominique Berton [France] ; Delphine Garbay [France] ; Claire Garnier Tixidre [France] ; David Coeffic [France] ; Aurelie Morvan [France] ; Olivier Collard [France] ; Thibault De La Motte Rouge [France]Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
000006 (2023) Xavier Pivot [France] ; Jean-Philippe Spano [France] ; Marc Espie [France] ; Christelle Jouannaud [France] ; Valerie Pottier [France] ; Laura Moreau [France] ; Jean Marc Extra [France] ; Alain Lortholary [France] ; Pascale Rivera [France] ; Dominique Spaeth [France] ; Zahira Mouri [France] ; Fella Tariket [France] ; Julien Dupin [France] ; Aurelien Berthois [France] ; Miruna Ionescu-Goga [France] ; Abdennour Ferhat [France] ; Paul Cottu [France] ; Joseph Gligorov [France]Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
000008 (2023) Caroline Bailleux [France] ; Antoine Arnaud [France] ; Jean-S Xe9 Bastien Frenel [France] ; Sylvie Chabaud [France] ; Thomas Bachelot [France] ; Beno Xee T You [France] ; La Xeb Titia Stefani [France] ; Claire Garnier Tixidre [France] ; H Xe9 L Xe8 Ne Simon [France] ; Dominique Beal-Ardisson [France] ; Jean-Philippe Jacquin [France] ; Francesco Del Piano [France] ; Alain Lortholary [France] ; Claudiu Cornea [France] ; Charlotte Greilsamer [France] ; R Xe9 My Largillier [France] ; Fabien Brocard [France] ; Eric Legouffe [France] ; Mustapha Atlassi [France] ; Anne-Claire Hardy-Bessard [France] ; Pierre-Etienne Heudel [France]CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
000009 (2022) Ang Xe9 Line Galvin [France] ; Nicolas Bertrand [France] ; Rabia Boulahssass [France] ; Laure De Decker [France] ; Xc9 Tienne Dorval [France] ; B Xe9 Atrice Clairaz [France] ; Monique Castaign Xe8 De [France] ; Lo Xef C Mourey [France] ; Capucine Baldini [France] ; Eric Bauvin [France] ; B Xe9 Atrice Jacques [France] ; Isabelle Mallon [France] ; Isabelle Durand-Zaleski [France] ; Olivier Gu Xe9 Rin [France] ; Sadek Krouri [France] ; Pierre Soubeyran [France][Rethinking the management of elderly cancer patients : Proposals from the Age Cancer Priorities French Group].
000010 (2022) Y. Pointreau [France] ; V. Sacier [France] ; F. Gilard [France] ; M. Balavoine [France] ; I. Latorzeff [France] ; E. Monpetit [France][Clinical research in radiotherapy oncology in private sector: A reality with a possible future?].
000015 (2022) Florence Joly [France] ; Michel Fabbro [France] ; Dominique Berton [France] ; Justine Lequesne [France] ; Am Xe9 Lie Anota [France] ; Alicja Puszkiel [France] ; Anne Floquet [France] ; H Xe9 L Xe8 Ne Vegas [France] ; Hugues Bourgeois [France] ; Le Xef La Bengrine Lefevre [France] ; Beno Xee T You [France] ; Fanny Pommeret [France] ; Alain Lortholary [France] ; Dominique Spaeth [France] ; Anne-Claire Hardy-Bessard [France] ; Cyril Abdeddaim [France] ; Marie-Christine Kaminsky-Forrett [France] ; Michel Tod [France] ; Jean-Emmanuel Kurtz [France] ; Francesco Del Piano [France] ; J Xe9 R Xf4 Me Meunier [France] ; Nadia Raban [France] ; J Xe9 Rome Alexandre [France] ; Marie-Ange Mouret-Reynier [France] ; Isabelle Ray-Coquard [France] ; Magali Provansal Gross [France] ; Pierre-Emmanuel Brachet [France]Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
000016 (2022) Bruno Laviolle [France] ; Vincent Diebolt [France] ; Luc Duchossoy [France] ; Xavier Anglaret [France] ; Jehan-Michel B Xe9 Hier [France] ; Pierre-Henri Bertoye [France] ; Anthony Chapron [France] ; Denis Comet [France] ; Catherine Cornu [France] ; C Xe9 Cile Fouret [France] ; Anne Galaup [France] ; Aur Xe9 Lie Gu Xe9 Rin [France] ; Bruno Hoen [France] ; Patrick Imbert [France] ; Marie Lang [France] ; Anne Le Louarn [France] ; Bastien Mezerette [France] ; Sophie S Xe9 N Xe9 Chal [France] ; Tabassome Simon [France] ; Pierre Traineau [France]Outpatient healthcare and clinical trials in the care pathway: Organisational and regulatory aspects and tools.
000018 (2022) Jean-David Fumet [France] ; Emilie Lardenois [France] ; Isabelle Ray-Coquard [France] ; Philipp Harter [Allemagne] ; Florence Joly [France] ; Ulrich Canzler [Allemagne] ; Caroline Truntzer [France] ; Olivier Tredan [France] ; Clemens Liebrich [Allemagne] ; Alain Lortholary [France] ; Daniel Pissaloux [France] ; Alexandra Leary [France] ; Jacobus Pfisterer [Allemagne] ; Alexandre Eeckhoutte [France] ; Felix Hilpert [Allemagne] ; Michel Fabbro [France] ; Christophe Caux [France] ; J Xe9 R Xf4 Me Alexandre [France] ; Aur Xe9 Lie Houlier [France] ; Jalid Sehouli [Allemagne] ; Emilie Sohier [France] ; Rainer Kimmig [Allemagne] ; Bertrand Dubois [France] ; Dominique Spaeth [France] ; Isabelle Treilleux [France] ; Jean-S Xe9 Bastien Frenel [France] ; Uwe Herwig [Allemagne] ; Olivia Le Saux [France] ; Nathalie Bendriss-Vermare [France] ; Andreas Du Bois [Allemagne]Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
000022